{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T23:17:39Z","timestamp":1778023059750,"version":"3.51.4"},"reference-count":74,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>The global tuberculosis (TB) epidemic caused by the bacterial pathogen Mycobacterium tuberculosis (M.tb) continues unabated. The Mycobacterium bovis bacillus Calmette\u2013Gu\u00e9rin (BCG) vaccination is widely utilized worldwide to protect against infection with M.tb. BCG vaccine protection against TB has had widely varying results for reasons that are not well understood. BCG vaccine interference by non-tuberculosis (NTM) mycobacterial species has been implicated as the potential cause of reduced BCG vaccine efficacy against M.tb. Ongoing efforts to develop new vaccines for TB requires a thorough understanding of the effect of NTM exposure on BCG vaccine efficacy, which may ultimately be a critical determinant of success. We reviewed the conflicting reports on whether NTM interferes with the BCG vaccine, potential explanations to help resolve the controversy, and strategies for developing better animal models. Further studies are needed to longitudinally track the effects of NTM exposure on BCG vaccine-induced host-protective anti-TB immunity.<\/jats:p>","DOI":"10.3390\/vaccines8040688","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T11:04:20Z","timestamp":1605524660000},"page":"688","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions"],"prefix":"10.3390","volume":"8","author":[{"given":"Deepshikha","family":"Verma","sequence":"first","affiliation":[{"name":"Department of Microbiology, Immunology and Pathology, Mycobacteria Research Laboratory, Colorado State University, 1682 Campus Delivery, 200 West Lake Street, Fort Collins, CO 80523, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7612-7727","authenticated-orcid":false,"given":"Edward D.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rocky Mountain Regional Veterans Affairs Medical Center, Denver, CO 80523, USA"},{"name":"Division of Pulmonary Sciences and Critical Care Medicine, Departments of Medicine and Academic Affairs, National Jewish Health, University of Colorado Anschutz Medical Campus, Denver, CO 80523, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0003-326X","authenticated-orcid":false,"given":"Diane J.","family":"Ordway","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology and Pathology, Mycobacteria Research Laboratory, Colorado State University, 1682 Campus Delivery, 200 West Lake Street, Fort Collins, CO 80523, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3389\/fimmu.2019.01317","article-title":"The Humoral Immune Response to BCG Vaccination","volume":"10","author":"Tanner","year":"2019","journal-title":"Front Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Bai, X., Feldman, N.E., Chmura, K., Ovrutsky, A.R., Su, W.-L., Griffin, L., Pyeon, D., McGibney, M.T., Strand, M.J., and Numata, M. (2013). Inhibition of nuclear factor-kappa B activation decreases survival of Mycobacterium tuberculosis in human macrophages. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061925"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/microbiolspec.TBTB2-0006-2016","article-title":"Regulation of Immunity to Tuberculosis","volume":"4","author":"Brighenti","year":"2016","journal-title":"Microbiol. Spectr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1002\/cpim.98","article-title":"Animal Models of Mycobacteria Infection","volume":"129","author":"Chan","year":"2020","journal-title":"Curr. Protoc. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1165\/rcmb.2008-0154TR","article-title":"What animal models teach humans about tuberculosis","volume":"39","author":"Dharmadhikari","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2249.1997.509-ce1407.x","article-title":"Cell-mediated immune responses to mycobacterial antigens in patients with pulmonary tuberculosis and HIV infection","volume":"110","author":"Silveira","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00408-010-9240-9","article-title":"Nontuberculous Mycobacteria and the Lung: From Suspicion to Treatment","volume":"188","author":"McGrath","year":"2010","journal-title":"Lung"},{"key":"ref_8","first-page":"257","article-title":"Mycobacterium avium complex in AIDS","volume":"12","author":"Bermudez","year":"1992","journal-title":"Curr. Clin. Top Infect Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1056\/NEJM199608083350602","article-title":"A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: Rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group","volume":"335","author":"Shafran","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1189\/jlb.4A0614-308RR","article-title":"Effect of bacillus Calmette-Gu\u00e9rin vaccination on CD4+Foxp3+ T cells during acquired immune response to Mycobacterium tuberculosis infection","volume":"99","author":"Arnett","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4049\/jimmunol.179.1.522","article-title":"The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation","volume":"179","author":"Ordway","year":"2007","journal-title":"J. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jcf.2019.05.013","article-title":"Clofazimine inhalation suspension for the aerosol treatment of pulmonary nontuberculous mycobacterial infections","volume":"18","author":"Banaschewski","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF00918660","article-title":"Functional immunoregulatory T-cell abnormalities in cystic fibrosis patients","volume":"9","author":"Lahat","year":"1989","journal-title":"J. Clin. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/resp.13245","article-title":"Tuberculosis vaccines: Opportunities and challenges","volume":"23","author":"Zhu","year":"2018","journal-title":"Respirology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1128\/IAI.70.2.672-678.2002","article-title":"Failure of the Mycobacterium bovis BCG vaccine: Some species of environmental mycobacteria block multiplication of BCG and induction of protective immunity to tuberculosis","volume":"70","author":"Brandt","year":"2002","journal-title":"Infect Immun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1586\/14760584.2016.1170599","article-title":"Why don\u2019t we have an effective tuberculosis vaccine yet?","volume":"15","author":"Davenne","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/infdis\/jiy207","article-title":"Does BCG Vaccination Protect Against Nontuberculous Mycobacterial Infection? A Systematic Review and Meta-Analysis","volume":"218","author":"Zimmermann","year":"2018","journal-title":"J. Infect Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0140-6736(96)02166-6","article-title":"Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi","volume":"348","author":"Fine","year":"1996","journal-title":"Lancet"},{"key":"ref_19","first-page":"21","article-title":"Tuberculosis prevention: Where do we go from here?","volume":"19","author":"Warndorff","year":"1996","journal-title":"Afr. Health"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4161\/hv.22464","article-title":"Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: A phase I clinical trial","volume":"9","author":"Rowland","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.3389\/fimmu.2017.01134","article-title":"What Have We Learnt about BCG Vaccination in the Last 20 Years?","volume":"8","author":"Dockrell","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1183\/09031936.00149212","article-title":"The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: An NTM-NET collaborative study","volume":"42","author":"Hoefsloot","year":"2013","journal-title":"Eur. Respir. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/ije\/dyx141","article-title":"The duration of protection of school-aged BCG vaccination in England: A population-based case-control study","volume":"47","author":"Mangtani","year":"2018","journal-title":"Int. J. Epidemiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-8518-8-3","article-title":"Assessment of immune response to repeat stimulation with BCG vaccine using in vitro PBMC model","volume":"8","author":"Kashyap","year":"2010","journal-title":"J. Immune Based Ther. Vaccines"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","article-title":"Prevention of tuberculosis in macaques after intravenous BCG immunization","volume":"577","author":"Darrah","year":"2020","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ccm.2014.10.002","article-title":"Epidemiology of human pulmonary infection with nontuberculous mycobacteria: A review","volume":"36","author":"Prevots","year":"2015","journal-title":"Clin. Chest Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.diagmicrobio.2012.05.035","article-title":"Patients with nontuberculous mycobacteria: Comparison of updated and previous diagnostic criteria for lung disease","volume":"74","author":"Epson","year":"2012","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s100960050447","article-title":"Evaluation of a Fluorescence Hybridisation Assay Using Peptide Nucleic Acid Probes for Identification and Differentiation of Tuberculous and Non-Tuberculous Mycobacteria in Liquid Cultures","volume":"19","author":"Padilla","year":"2000","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3201\/eid1602.090675","article-title":"Increasing Incidence of Nontuberculous Mycobacteria, Taiwan 2000\u20132008","volume":"16","author":"Lai","year":"2010","journal-title":"Emerg. Infect. Dis. J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.diagmicrobio.2011.09.009","article-title":"Pulmonary infection caused by nontuberculous mycobacteria in a medical center in Taiwan 2005\u20132008. Diagn","volume":"72","author":"Chen","year":"2012","journal-title":"Microbiol. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2169\/internalmedicine.52.8907","article-title":"Mixed Pulmonary Infection with Three Types of Nontuberculous Mycobacteria","volume":"52","author":"Kurahara","year":"2013","journal-title":"Intern. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1126\/science.aaf8156","article-title":"Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium","volume":"354","author":"Bryant","year":"2016","journal-title":"Science"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1128\/CMR.17.1.98-106.2004","article-title":"Health impacts of environmental mycobacteria","volume":"17","author":"Primm","year":"2004","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Chouhan, D., Devi, T.B., Chattopadhyay, S., Dharmaseelan, S., Nair, G.B., Devadas, K., and Pillai, R.M. (2019). Mycobacterium abscessus infection in the stomach of patients with various gastric symptoms. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007799"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.1128\/iai.60.11.4747-4753.1992","article-title":"Dissemination of enteric Mycobacterium avium infections in mice rendered immunodeficient by thymectomy and CD4 depletion or by prior infection with murine AIDS retroviruses","volume":"60","author":"Orme","year":"1992","journal-title":"Infect Immun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.suc.2005.05.009","article-title":"Anatomy and physiology of the stomach","volume":"85","author":"Soybel","year":"2005","journal-title":"Surg. Clin. N. Am."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1164\/rccm.201003-0503OC","article-title":"Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: An emerging public health disease","volume":"182","author":"Winthrop","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1165\/rcmb.2009-0276TR","article-title":"Host immune response to rapidly growing mycobacteria, an emerging cause of chronic lung disease","volume":"43","author":"Chan","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1164\/rccm.201206-1035OC","article-title":"Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes","volume":"187","author":"Kartalija","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1378\/chest.15-0458","article-title":"Pulmonary Disease Due to Nontuberculous Mycobacteria: Current State and New Insights","volume":"148","author":"McShane","year":"2015","journal-title":"Chest"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1128\/CMR.00060-07","article-title":"Cavitary pulmonary disease","volume":"21","author":"Gadkowski","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1016\/j.clnu.2018.09.019","article-title":"Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation","volume":"38","author":"Kamo","year":"2019","journal-title":"Clin. Nutr."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Shang, S., Gibbs, S., Henao-Tamayo, M., Shanley, C.A., McDonnell, G., Duarte, R.S., Ordway, D.J., and Jackson, M. (2011). Increased virulence of an epidemic strain of Mycobacterium massiliense in mice. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0024726"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Sable, S.B., Posey, J.E., and Scriba, T.J. (2019). Tuberculosis Vaccine Development: Progress in Clinical Evaluation. Clin. Microbiol. Rev., 33.","DOI":"10.1128\/CMR.00100-19"},{"key":"ref_45","first-page":"687","article-title":"1993 Fred Griffith Review Lecture. Foods and microbiological risks","volume":"140","year":"1994","journal-title":"Microbiology (Read.)"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2460\/javma.246.4.419","article-title":"Pathology in practice. Pemphigus vulgaris","volume":"246","author":"Blair","year":"2015","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jpedsurg.2018.10.030","article-title":"Surgical treatment of congenital hyperinsulinism: Results from 500 pancreatectomies in neonates and children","volume":"54","author":"Adzick","year":"2019","journal-title":"J. Pediatr. Surg."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1111\/cas.14212","article-title":"Reduction in HPV16\/18 prevalence among young women with high-grade cervical lesions following the Japanese HPV vaccination program","volume":"110","author":"Matsumoto","year":"2019","journal-title":"Cancer Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/ehjqcco\/qcz018","article-title":"The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry","volume":"5","author":"Habib","year":"2019","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"6374","DOI":"10.1002\/anie.201703696","article-title":"Gerd Becker (1940\u20132017)","volume":"56","author":"Uhl","year":"2017","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/sim.5408","article-title":"Social contagion theory: Examining dynamic social networks and human behavior","volume":"32","author":"Christakis","year":"2013","journal-title":"Stat Med."},{"key":"ref_52","first-page":"124","article-title":"Bird Keeper\u2019s lung without bird keepinge","volume":"5","author":"Greinert","year":"2000","journal-title":"Eur. J. Med. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10875-019-0593-4","article-title":"Immunological, and Clinical Features of 16 Iranian Patients with Mendelian Susceptibility to Mycobacterial Disease","volume":"39","author":"Sarrafzadeh","year":"2019","journal-title":"J. Clin. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0140-6736(12)61350-6","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: A meta-analysis","volume":"380","author":"Fox","year":"2012","journal-title":"Lancet"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"ref_56","first-page":"502131","article-title":"Tai chi chuan in medicine and health promotion","volume":"2013","author":"Lan","year":"2013","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1128\/AAC.00459-15","article-title":"Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models","volume":"59","author":"Arnett","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Huang, H.-Y., Chung, F., Lo, C.-Y., Lin, H.-C., Huang, Y.-T., Yeh, C.-H., Lin, C.-W., Huang, Y.-C., and Wang, C.-H. (2020). Etiology and characteristics of patients with bronchiectasis in Taiwan: A cohort study from 2002 to 2016. BMC Pulm. Med., 20.","DOI":"10.1186\/s12890-020-1080-7"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccm.2014.10.001","article-title":"Pathogenesis and risk factors for nontuberculous mycobacterial lung disease","volume":"36","author":"Honda","year":"2015","journal-title":"Clin. Chest Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.coi.2018.06.001","article-title":"Acquired and genetic host susceptibility factors and microbial pathogenic factors that predispose to nontuberculous mycobacterial infections","volume":"54","author":"Honda","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/0019-5413.201718","article-title":"Nontuberculous mycobacterial infection of the musculoskeletal system in immunocompetent hosts","volume":"51","author":"Gundavda","year":"2017","journal-title":"Indian J. Orthop."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/15412550903085193","article-title":"Extracellular superoxide dismutase and risk of COPD","volume":"6","author":"Regan","year":"2009","journal-title":"COPD"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Meoli, A., Deolmi, M., Iannarella, R., and Esposito, S. (2020). Non-Tuberculous Mycobacterial Diseases in Children. Pathogens, 9.","DOI":"10.3390\/pathogens9070553"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"11290","DOI":"10.1038\/ncomms11290","article-title":"T-cell activation is an immune correlate of risk in BCG vaccinated infants","volume":"7","author":"Fletcher","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Yeh, J.-J., Wang, Y.-C., Sung, F.-C., and Kao, C.-H. (2014). Rheumatoid arthritis increases the risk of nontuberculosis mycobacterial disease and active pulmonary tuberculosis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0110922"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40572-016-0086-z","article-title":"Current Epidemiologic Trends of the Nontuberculous Mycobacteria (NTM)","volume":"3","author":"Falkinham","year":"2016","journal-title":"Curr. Environ. Health Rep."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1128\/IAI.01826-06","article-title":"Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination","volume":"75","author":"Young","year":"2007","journal-title":"Infect Immun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.1086\/321851","article-title":"Perspective on Animal Models: Chronic Intracellular Infections","volume":"33","author":"Young","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/infdis\/165.1.75","article-title":"An Animal Model of Mycobacterium avium Complex Disseminated Infection after Colonization of the Intestinal Tract","volume":"165","author":"Bermudez","year":"1992","journal-title":"J. Infect. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fimmu.2019.00234","article-title":"BCG Vaccination Induces M. avium and M. abscessus Cross-Protective Immunity","volume":"19","author":"Abate","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5071","DOI":"10.1128\/IAI.00457-09","article-title":"Cross-Reactive Immunity to Mycobacterium tuberculosis DosR Regulon-Encoded Antigens in Individuals Infected with Environmental, Nontuberculous Mycobacteria","volume":"77","author":"Lin","year":"2009","journal-title":"Infect. Immun."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.0019-2805.2003.01807.x","article-title":"Limited role of the Toll-like receptor-2 in resistance to Mycobacterium avium","volume":"111","author":"Gomes","year":"2004","journal-title":"Immunology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00281-003-0148-9","article-title":"Mycobacteria and other environmental organisms as immunomodulators for immunoregulatory disorders","volume":"25","author":"Rook","year":"2004","journal-title":"Springer Semin. Immunopathol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1128\/IAI.73.6.3577-3586.2005","article-title":"Gamma Interferon-Induced T-Cell Loss in Virulent Mycobacterium avium Infection","volume":"73","author":"Pearl","year":"2005","journal-title":"Infect. Immun."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/4\/688\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:34:05Z","timestamp":1760178845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/8\/4\/688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":74,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["vaccines8040688"],"URL":"https:\/\/doi.org\/10.3390\/vaccines8040688","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,16]]}}}